Mike’s Hatch-Waxman experience includes a successful 4-week trial for a pharmaceutical product with more than $6 billion in annual sales. He has counseled his pharmaceutical clients in numerous therapeutic categories, including: proton pump inhibitors, antipsychotics, antibiotics, antineoplastic agents, aromatase inhibitors, hypnotic agents, partial dopamine agonists, anti-thrombotic agents, and chemotherapy agents.
In addition to Hatch-Waxman, Mike has litigated matters concerning general commercial disputes, real estate financing, financing of insurance premiums, the launch of IBM's next-generation business process management software, LED fluorescent replacement tubes, and copyright rights to an artist’s comic book characters.
Outside of litigation, Mike has worked on M&A due diligence projects, including the intellectual property due diligence for a $3.2 billion acquisition of a pharmaceutical company and due diligence projects for Series A and B financing rounds.
Mike's master's degree in biology has reaches beyond the law. He has been an adjunct professor at both the New York Institute of Technology and Hofstra University, teaching classes on anatomy, plant physiology, and a science survey class covering physics, chemistry, biology, and ecology.
During law school, Mike had the privilege of interning with Edgardo Ramos at the U.S. Attorney's Office—Judge Ramos is now a District Court Judge for the United States District Court for the Southern District of New York. He was also on the executive board of his law review. More recently, Mike was selected for inclusion in Super Lawyers – Rising Stars Edition, Thomson Reuters, Intellectual Property Litigation, in 2013 and 2014.